Sudhir Gupta
Overview
Explore the profile of Sudhir Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
3264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kobayashi R, Maltese J, Litzman J, Kreuwel H, Zekoll T, Kobayashi A, et al.
Immunotherapy
. 2024 Dec;
16(20-22):1235-1245.
PMID: 39648657
This report delves into the challenges and potential solutions associated with flexible, customized subcutaneous immunoglobulin (SCIG) infusion regimens for patients with primary antibody deficiency disease (PAD). Advances in the treatment...
2.
Rubinstein A, Mabudian M, McNeil D, Patel N, Wasserman R, Gupta S, et al.
J Clin Immunol
. 2024 Aug;
44(8):181.
PMID: 39158670
Facilitated subcutaneous immunoglobulin (fSCIG) 10% is an immunoglobulin replacement therapy that utilizes recombinant human hyaluronidase (rHuPH20) to enhance immunoglobulin dispersion and absorption, allowing for longer treatment intervals similar to intravenous...
3.
Jung Y, Agrawal S, Wang B, Gupta S
Dermatopathology (Basel)
. 2024 Jul;
11(3):218-229.
PMID: 39051325
IgG4-RD is a multisystem fibroinflammatory disease characterized by the infiltration of tissues by IgG4 plasma cells. Combined skin and biliary tract involvement in IgG4-RD has not been described. We present...
4.
Adaptive Cellular Responses following SARS-CoV-2 Vaccination in Primary Antibody Deficiency Patients
Gupta S, Su H, Agrawal S, Demirdag Y, Tran M, Gollapudi S
Pathogens
. 2024 Jun;
13(6).
PMID: 38921811
Since the start of the COVID-19 pandemic, in a short span of 3 years, vaccination against SARS-CoV-2 has resulted in the end of the pandemic. Patients with inborn errors of...
5.
Thangaraj A, Tyagi R, Suri D, Gupta S
Pathogens
. 2024 Mar;
13(3).
PMID: 38535602
Primary immune regulatory disorders (PIRDs) constitute a spectrum of inborn errors of immunity (IEIs) that are primarily characterized by autoimmunity, lymphoproliferation, atopy, and malignancy. In PIRDs, infections are infrequent compared...
6.
Kasahara T, Gupta S
Pathogens
. 2024 Feb;
13(2).
PMID: 38392874
Common variable immunodeficiency (CVID) is the most frequent form of primary hypogammaglobulinemia in adults. In addition to recurrent infections and respiratory manifestations, CVID patients may present several non-infection complications such...
7.
Kunwar A, Kaur P, Durgad K, Parasuraman G, Sharma M, Gupta S, et al.
PLoS One
. 2023 Dec;
18(12):e0295338.
PMID: 38096180
Background: Antihypertensive drug supply is sometimes inadequate in public sector health facilities in India. One of the core strategies of the India Hypertension Control Initiative (IHCI) is to improve the...
8.
Vollmer C, Dias A, Sales M, Sacramento P, Silva J, Oyamada H, et al.
Front Immunol
. 2023 Nov;
14:1290740.
PMID: 37954580
Introduction: Obesity can complicate IgE-mediated allergic diseases. In the present study, we aimed to investigate the ability of obesity-related concentrations of leptin to modulate the effector and regulatory Fel d1-specific...
9.
Gupta S, DeAngelo J, Melamed I, Walter J, Kobayashi A, Bridges T, et al.
J Clin Immunol
. 2023 May;
43(6):1414-1425.
PMID: 37160610
Purpose: To achieve reductions in infusion time, infusion sites, and frequency, a prospective, open-label, multicenter, Phase 3 study evaluated the safety, efficacy, and tolerability of subcutaneous immunoglobulin (SCIG) 16.5% (Cutaquig®,...
10.
Demirdag Y, Gupta S
Pathogens
. 2023 Mar;
12(3).
PMID: 36986362
DNA repair defects are heterogenous conditions characterized by a wide spectrum of clinical phenotypes. The common presentations of DNA repair defects include increased risk of cancer, accelerated aging, and defects...